Bonestrong
Natural health product licensed in Canada
- Licence holder
- Wing Quon Enterprises Ltd.
- NPN or DIN-HM
- 80036027
- Status
- Active licence
- Licence date
- 29 September 2012
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Carthamus tinctorius Source : Fleur(s) séchée | 35 mg | Not calculated |
| myrrhe Source : Résine | 24 mg | Not calculated |
| Psoralea corylifolia Source : Fruit mûr séché | 35 mg | Not calculated |
| Drynaria fortunei Source : Rhizome séché | 30 mg | Not calculated |
Non-medicinal ingredients
Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3 Pilule ; maximum: 4 Pilule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditional Chinese medicine to relieve pain on lumbar and knees, arthralgia pain due to wind dampness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036027
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.